Illumina Inc's shares saw a significant boost as analysts raised their price targets, showing optimism about the company's future.
Illumina Inc (NASDAQ:ILMN) rose by 7.56% yesterday, closing at $293.84. This increase followed analysts revising their price targets upward, driven by expectations of improved clinical sales and the growing recognition of gene-sequencing technology as essential for artificial intelligence applications.
Advertisement
Illumina Inc
ILMN.US
ILMN.US
Illumina Inc
WealthAwesomeMarket cap
$44.35B
P/E
54.8x
52W high
$296.25
52W low
$88.00
1W change
+8.01%
Beta
1.42
Analyst Price Targets
Based on 21 analysts covering ILMN · as of Oct 6, 2026
Wall Street analysts forecast ILMN stock price to fall 24.5% over the next 12 months.
Consensus
Buy3.57 / 5.00
Avg. Target
C$221.85
-24.5% Upside
Previously C$214.60 on Oct 5, 2026
Current Price
C$293.69
Last close
Analyst Breakdown (21 analysts)
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on ILMN's historical volatility
30-Day Vol
52.8%
Annualized
90-Day Vol
46.4%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$351.11
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$311.70 | C$259.80 – C$373.98 |
| 60 trading days | C$330.82 | C$255.69 – C$428.02 |
| 90 trading days | C$351.11 | C$256.11 – C$481.35 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should pay attention to the positive sentiment around Illumina's innovative technology and its potential for future growth, especially in the AI sector.
Illumina's stock up 7.56% yesterday
The stock has gained 119% year-to-date, reflecting strong market interest and investor confidence in its growth potential.
Bull case
Analysts' upward revision of price targets shows strong confidence in Illumina's growth trajectory. Their gene-sequencing technology is increasingly viewed as crucial for AI applications, which bodes well for the company’s future.
Bear case
Despite the recent surge, Illumina's stock remains volatile. Past performance indicates that significant gains can be followed by sharp declines, raising concerns about sustainability.
Advertisement
Analysts Boost Price Targets
Illumina's recent stock surge was driven by analysts increasing their price targets based on expected improvements in clinical sales. As the demand for genomic data grows, analysts believe Illumina's technology will be vital in various applications, including artificial intelligence.
Market Sentiment and Volatility
While the stock's 7.56% increase reflects positive market sentiment, Illumina has experienced significant volatility in the past. Investors should stay cautious, as the stock has had multiple large moves throughout the year, suggesting a potentially unstable investment environment.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
